Jim Cramer’s Latest Lightning Round: Top 10 Stocks
Jim Cramer in a latest program on CNBC said that the market has already priced in the expected positive comments from the Fed Chair Jerome Powell at the Jackson Hole event in Wyoming.
Royalty Pharma Plc (RPRX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Viking Global Andreas Halvorsen | 11,970,058 | $315,650,429 | +5% | 1.21% |
| 2. | Adage Capital Management Phill Gross And Robert Atchinson | 10,931,931 | $288,275,020 | +2% | 0.53% |
| 3. | GMT Capital Thomas E. Claugus | 2,427,100 | $64,002,627 | +35% | 2.36% |
| 4. | Millennium Management Israel Englander | 2,350,280 | $61,976,884 | -50% | 0.02% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 2,096,300 | $55,279,431 | +38% | 0.12% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $29.51 | 130,000 | Large Shareholder, Officer, Director | 600,000 | 2023-06-28 | Filing | |
| $32.78 | 45,000 | Large Shareholder, Officer, Director | 470,000 | 2023-06-13 | Filing | |
| $33.00 | 45,000 | Large Shareholder, Officer, Director | 425,000 | 2023-06-12 | Filing | |
| $32.25 | 150,000 | Large Shareholder, Officer, Director | 380,000 | 2023-05-24 | Filing | |
| $32.94 | 69,612 | Large Shareholder, Officer, Director | 230,000 | 2023-05-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $27.55 | 35,702 | Director | 20,099 | 2024-01-04 | Filing | |
| $27.79 | 199,098 | Director | 55,801 | 2024-01-03 | Filing | |
| $28.52 | 235,200 | Director | 254,899 | 2024-01-02 | Filing | |
| $28.04 | 65,803 | 2,477,520 | 2023-12-29 | Filing | ||
| $28.20 | 209,863 | 2,543,323 | 2023-12-28 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 46,354,266 | $1,302,091,425 | 0.11% | |
| 2. | 37,997,522 | $1,067,350,392 | 0.02% | |
| 3. | 31,583,929 | $887,192,558 | 0.06% | |
| 4. | 21,459,462 | $602,796,290 | 0.01% | |
| 5. | 17,590,450 | $494,115,741 | 0.4% |
News See All
10 Best Defensive Stocks To Buy Now
Defensive stocks tend to remain stable and less affected by economic downturns.
Royalty Pharma plc (NASDAQ:RPRX) Q2 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to Royalty Pharma Second Quarter Earnings Conference Call.
Should You Consider Adding Royalty Pharma plc (RPRX) to Your Portfolio?
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Best Undervalued Stocks To Buy Now
In the prior couple of years, experts and analysts were worried about a recession in the US and their best-case scenario was a soft landing. Experts are still predicting the latter.
Royalty Pharma plc (NASDAQ:RPRX) Q1 2024 Earnings Call Transcript
Royalty Pharma plc misses on earnings expectations. Reported EPS is $0.008 EPS, expectations were $0.96.
30 Most Profitable Companies with Highest Margins in the World
In this article, we will be taking a look at the 30 Most Profitable Companies with Highest Margins in the World.
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
5 Most Undervalued Biotech Stocks To Buy According To Hedge Funds
In this article, we discuss 5 most undervalued biotech stocks to buy according to hedge funds.
Royalty Pharma plc (NASDAQ:RPRX) Q4 2023 Earnings Call Transcript
Royalty Pharma plc beats earnings expectations. Reported EPS is $1.15, expectations were $1.01.
Billionaire Hedge Funds
